Related Content
January 8, 2013 — Abbott announced the initiation of the ABSORB III clinical trial in patients in the United States. The ...
January 3, 2013 — Abbott announced that the Xience Xpedition everolimus-eluting coronary stent system received U.S. Food ...
December 19, 2012 — Acute chest pain is one of the most common reasons people seek emergency care, and time is a ...
For chronic mitral valve regurgitation (MR) from degenerative disease, conventional open surgery provides a durable ...
November 2, 2012 — Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are ...
September 28, 2012 — The world’s first drug-eluting bioabsorbable vascular scaffold has been launched and will ...
September 26, 2012 — Abbott Vascular this week began its international launch of the Absorb coronary stent, the world's ...
August 20, 2012 — Abbott today announced that the Xience Xpedition everolimus-eluting coronary stent system received CE ...
August 9, 2012 — The Harvard Clinical Research Institute (HCRI) announced today the successful completion of ...
Aug. 8, 2012 — The U.S. Food and Drug Administration (FDA) has approved Abbott’s Omnilink Elite Vascular Balloon ...